Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
QuintilesIMS
Dow
Mallinckrodt
Medtronic
AstraZeneca
Express Scripts
Chinese Patent Office
McKinsey
Novartis

Generated: January 19, 2018

DrugPatentWatch Database Preview

Mcneil Cons Company Profile

« Back to Dashboard

What is the competitive landscape for MCNEIL CONS, and what generic and branded alternatives to MCNEIL CONS drugs are available?

MCNEIL CONS has seven approved drugs.



Summary for Mcneil Cons
US Patents:0
Tradenames:5
Ingredients:4
NDAs:7

Drugs and US Patents for Mcneil Cons

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mcneil Consumer MOTRIN ibuprofen TABLET;ORAL 017463-005 May 22, 1985 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mcneil Cons NICOTROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020536-001 Jul 3, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mcneil Cons BENADRYL diphenhydramine hydrochloride CAPSULE;ORAL 005845-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mcneil Cons BENADRYL diphenhydramine hydrochloride INJECTABLE;INJECTION 006146-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mcneil Cons BENADRYL diphenhydramine hydrochloride INJECTABLE;INJECTION 006146-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mcneil Cons SUDAFED 12 HOUR pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 073585-001 Oct 31, 1991 OTC No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mcneil Consumer MOTRIN ibuprofen TABLET;ORAL 017463-004 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mcneil Consumer MOTRIN ibuprofen TABLET;ORAL 017463-003 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mcneil Consumer MOTRIN ibuprofen TABLET;ORAL 017463-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mcneil Cons BENADRYL diphenhydramine hydrochloride CAPSULE;ORAL 005845-007 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Mcneil Cons

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mcneil Cons NICOTROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020536-001 Jul 3, 1996 ➤ Subscribe ➤ Subscribe
Mcneil Cons NICOTROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020536-001 Jul 3, 1996 ➤ Subscribe ➤ Subscribe
Mcneil Consumer MOTRIN ibuprofen SUSPENSION;ORAL 019842-001 Sep 19, 1989 ➤ Subscribe ➤ Subscribe
Mcneil Cons NICOTROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020536-001 Jul 3, 1996 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
US Army
Julphar
Cantor Fitzgerald
Boehringer Ingelheim
Accenture
Covington
Novartis
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot